NCT03528135
- Conditions
- Acquired Immunodeficiency Syndrome, Anxiety, Anxiety Disorders, +27 more
- Locations
-
- Avenue 360, University of Houston Houston, Texas, United States
Clinical trial condition
Acquired Immunodeficiency Syndrome
Explore clinical trials studying Acquired Immunodeficiency Syndrome. Study availability and eligibility vary by location and protocol.
2,558 public trials
178 recruiting studies
Acquired Immunodeficiency Syndrome trial results
NCT04560556
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- DC Department of Corrections Washington D.C., District of Columbia, United States
NCT04122404
- Conditions
- Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +29 more
- Locations
-
- Korle Bu Teaching Hospital Accra, Ghana
- Tema General Hospital Tema, Ghana
- Lekma Hospital Teshie, Ghana
Completed
COVID-19 in Patients With HIV
NCT04333953
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, COVID-19, +28 more
- Locations
-
- University of Missouri-Columbia Columbia, Missouri, United States
NCT03249493
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
- Locations
-
- Yen Bai medical center Yên Bái, Vietnam
NCT04036851
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Gugulethu Community Health Centre Cape Town, Western Cape, South Africa
NCT03529409
- Conditions
- Acquired Immunodeficiency Syndrome, Alcohol Drinking, Alcohol-Related Disorders, +23 more
- Locations
-
- University of Maryland College Park, Maryland, United States
- University of Cape Town Cape Town, South Africa
NCT03200054
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Gugulethu Community Health Centre Cape Town, Western Cape, South Africa
NCT03673098
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Completed
A Phase I Trial to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer Vaccine, Adjuvanted
NCT03547245
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- George Washington University Washington D.C., District of Columbia, United States
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States